Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy.
Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor.
Myelination: Actin Disassembly Leads the Way.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
[Pediatric multiple sclerosis].
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
[Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Caregiver burden in multiple sclerosis: A structured review of the instruments.
Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
[Knowing more about oneself to help one care for others].
Exploration of Undertreatment and Patterns of Treatment of Depression in Multiple Sclerosis.
Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study.
Cerebral adenosine A1 receptors are upregulated in rodent encephalitis.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.
Clinical prospective study of visual function in patients with acute optic neuritis.
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Immunomodulation by Sub-Chronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Pages
« first
‹ previous
…
547
548
549
550
551
552
553
554
555
…
next ›
last »